Business Context and Reporting Period
This Form 8-K Current Report was filed by vTv Therapeutics Inc. on June 23, 2020. The report discloses a corporate governance event regarding the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial statements or performance data.
Material Changes
Departure of Director: On June 23, 2020, Paul G. Savas resigned from the Board of Directors, effective immediately. The Company stated that Mr. Savas did not resign due to any disagreement with the Company regarding its operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the standard disclosure of the director's resignation.
Key Facts for Investor Verification
- Paul G. Savas resigned from the Board of Directors effective June 23, 2020.
- The resignation was not attributed to any disagreement with the Company.
- The Company is an emerging growth company listed on the NASDAQ Capital Market under the symbol VTVT.
- No financial performance data is included in this specific filing.